This message was sent to ##Email##
Get ready for Baltimore with a few tips
Stay Connected with the ASHI Mobile App
The ASHI 2018 app serves as your all-in-one event guide putting everything you need to know in your pocket on your mobile device. This is the best way to access complete event information, view the program and build your personal schedule, access abstracts, and stay connected with daily reminders and updates at the meeting.
Download it for FREE! Search ASHI 2018 in the App or Google Play stores.
View Meeting Abstracts Now
View all abstracts that will be presented in Baltimore online. This site allows you to search abstracts by schedule, topic, abstract, and author name. More Information Here
Download the Final Program
As in previous years, ASHI is promoting a green initiative so printed copies of the program will not be available onsite. We recommend the Mobile App as the best way to see the schedule, but you can also download the final program and print it yourself, prior to the meeting. Download it Here
Special Events at the ASHI Meeting
This year’s meeting features a brand new Silent Auction to benefit the ASHI Travel Fund, and brings back classic events like the Tulip 5K/1 Mile Fun Run and the Thursday night Networking Reception. Read More and Mark Your Calendars Now!
Click here to learn more about ASHI committee roles and responsibilities.
Looking for a small way to give back? If you’re attending this year’s ASHI Annual Meeting, consider volunteering to assist with the Silent Auction. One-hour time slots are available Monday, October 1 – Wednesday, October 3. Contact Mandi Cruz at Mcruz@ashi-hla.org to sign-up today!
Sign up to volunteer today by clicking here or contact Mandi Cruz at Mcruz@ashi-hla.org for more information.
We are pleased to announce the newly-elected ASHI board members! Their terms will begin at the conclusion of the Annual Business Meeting in Baltimore.
Medhat Z. Askar, MD, PhD, D(ABHI)
Dean Sylvaria, BS, CHS
Board of Directors (Non-doctoral)
Brett D. Loehmann, BS, CHS, CHT, CTBS
ASHI Bylaws Revisions
The Membership Committee’s recommendation to revise the approval process of membership applications has been approved. The ASHI Bylaws has been updated to the following:
Article II. Section 4. Application for Membership.
Applications for membership and membership renewal will be automatically approved upon receipt of application. The Membership Committee chair, or designated Membership Committee member, may randomly review applications to assure that applicants have applied for the category of membership that best fits the applicant's stated criteria. Decisions of the Chair of the Membership Committee may be appealed to the Board of Directors.
HLA Typing, NGS, almost no ambiguity, Affordable, Accurate, Quick turnaround time. Reports are uploaded to compatible laboratory software. HLA antibody identification by SAB or C1q, KIR typing, Cancer gene screening and many more.
Questions regarding our testing or to discuss your needs, please contact us at 972-566-8478, 972-566-6278 or 972-566-5761 or visit our website at texasmedicalspecialty.com.
Come visit Claude the Crab at the Tulip Run – 6th Annual 5K Run/1 Mile Walk
Join me for a morning 5k run or 1 mile walk through Patterson Park in Baltimore on Wednesday, October 3 from 6:30 am – 8:30 am. Proceeds from this event will benefit the Living Legacy Foundation of Maryland. All runners and walkers are welcome.
NEW THIS YEAR! Warm-up with a local yoga instructor who will guide us through gentle stretches to prepare for the run/walk. Begins at 6:00 am. Read more and add the run to your registration today!
Name & Credentials: David Partlow, MS, MBA MT(ASCP), CHS(ABHI)
Place of employment: The University of Texas MD Anderson Cancer Center
Graduated from: The University of Texas Medical Branch
How long have you been an ASHI member? 10-15 years
When did you attend your first ASHI Meeting? I think my first ASHI meeting was a regional meeting where Dr. Stastny presented the year after he was the ASHI president. The one memory that sticks out was being introduced to Dr. Stastny and that our lab director had worked with him at UT Southwestern in Dallas.
Click here to read more.
To be our next ASHI Member Spotlight, click here now! You can also nominate a co-worker or fellow colleague by contacting Mandi Cruz at Mcruz@ashi-hla.org.
Unexpected software complications have led to an extended review and finalization process for the 2018 PT reports. The patience and understanding exhibited by the ASHI PT subscribers has been greatly appreciated during this challenging PT season.
Adjustments to the 2018 AC-1 Performance Reports have been ongoing and continue as of the date of this writing. AC-1 participants will receive an announcement notifying them of the availability of the AC-1 Performance and Summary Reports once they are posted in the Lab Center. In the meantime, the 2018 AC-1 Summary Report was released to AC-1 participants by email on Wednesday, September 12th as a PDF attachment.
The 2018 HT-2 samples were shipped to HT-2 participants on Tuesday, September 11, 2018. The results for the HT-2 survey are due by 11:59pm Pacific time on Friday, October 19, 2018. (Reminder: Results that have not been submitted by the deadline will not be accepted.)
The 18th International Symposium on Bone Marrow Transplantation will be held in Mexico City from October 24 - 27, 2018 at The National Academy of Medicine. The symposium is intended for a bilingual audience. Please click here to view the preliminary schedule on the symposium brochure.
Standard Rate: $250.00 USD
Medical Residents and Students: $150.00 USD
For more information, click here.
Dr. Effie Petersdorf and ASHI Member/Board Member, Dr. Rob Liwski, are confirmed speakers at the Asia–Pacific Histocompatibility & Immunogenetics Association (APHIA) conference held on November 11 – 14, 2018 at the Sydney Masonic Center in Sydney.
For additional conference details, please visit aphia2018.org.
ABHI is excited to announce the development of a new "CE Center" website with features that will enable you to:
✔ Pay your annual dues online. No more paper invoices!
Watch for more information on the new ABHI CE Center at the ASHI Annual Meeting in Baltimore, and your email inbox, coming this fall.
✔ Monitor your 3-year certification period in a clear, concise dashboard. See how many more credits you need to complete!
✔ Upload continuing education activities & certificates that you have completed (CE credits & CECs included!)
✔ Update personal information such as your address, email, etc.
Have you renewed your ASHI membership for 2019? If not, do it now to avoid a disruption of your ASHI benefits!
Your ASHI Membership will expire on December 31, 2018. Your membership dues allow us to provide programs, professional awards, and educational opportunities that advance the science, education and application of immunogenetics and transplant immunology. Click here to renew today!
If you are experiencing trouble with your ASHI website username or password, contact Membership Coordinator, Mandi Cruz at email@example.com.
The ASHI Directors' Mentor / Mentee Program is dedicated to helping new Directors advance in their careers. The program pairs new Directors with more experienced Directors on an informal basis for the purpose of providing one-on-one guidance and advice to the newer Directors (mentees).
To learn more about the ASHI Directors' Mentor / Mentee Program, click here. Complete the mentor questionnaire and sign up today!
This report shows the HLA-A, -B, -C, -DRB1 and -DQB1 allele and haplotype frequencies in a population of 127 healthy Ossetian donors of blood marrow from Vladikavkaz, Russia.
Successful solid organ transplantation currently requires the life-long use of medications to suppress the immune system in order to prevent transplant rejection. Drug-based immunosuppression significantly increases the risk of infection and cancer, as well as being very costly.
Interleukin 17 (IL-17) plays important roles in the progression of asthma. Genetic variants in the Il-17 may influence the immunopathogenesis of many diseases. Many studies have investigated the relevance of IL-17 polymorphism with cancers or immune diseases, including asthma.
American Journal of Transplantation
Currently, the ability to predict or monitor the efficacy of HLA antibody–removal therapies is deficient. We previously reported that titration studies are a consistent and accurate means of assessing antibody strength. To test whether titration studies can also predict which patients are better candidates for desensitization, we studied 38 patients from 3 centers (29 receiving plasmapheresis/low‐dose intravenous immunoglobulin [IVIg]; 9 patients receiving high‐dose IVIg).
*As recommended by the Science & Technology Initiatives Committee
Antibody-mediated rejection is a major cause of premature graft loss in kidney transplantation. Multiple scoring systems are available to assess the HLA mismatch between donors and recipients at the molecular level; however, their correlation with the development of de novo donor-specific antibody (dnDSA) has not been compared in recipients on active immunosuppression.
*As recommended by the Science & Technology Initiatives Committee
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8